EDITORIAL
Published on 11 Nov 2021
Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
doi 10.3389/fphar.2021.794854
- 1,341 views
- 9 citations
- Frontiers in Pharmacology
- Inflammation Pharmacology
- Research Topics
- Novel Anti-inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
Novel Anti-inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
31k
Total Downloads
95k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 14 May 2021
Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells
doi 10.3389/fphar.2021.592184
- 2,353 views
- 10 citations
ORIGINAL RESEARCH
Published on 13 May 2021
Enhancing Cystic Fibrosis Immune Regulation
doi 10.3389/fphar.2021.573065
- 3,091 views
- 12 citations
MINI REVIEW
Published on 15 Apr 2021
Cystic Fibrosis Lung Disease in the Aging Population
doi 10.3389/fphar.2021.601438
- 5,044 views
- 11 citations
ORIGINAL RESEARCH
Published on 30 Mar 2021
Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
doi 10.3389/fphar.2021.628722
- 2,537 views
- 27 citations
MINI REVIEW
Published on 11 Mar 2021
Update on Calcium Signaling in Cystic Fibrosis Lung Disease
doi 10.3389/fphar.2021.581645
- 4,861 views
- 22 citations
ORIGINAL RESEARCH
Published on 29 Jan 2021
Protective Effects of Pterostilbene on Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting NF-κB and Activating Nrf2/HO-1 Signaling Pathways
doi 10.3389/fphar.2020.591836
- 3,583 views
- 32 citations
ORIGINAL RESEARCH
Published on 27 Jan 2021
Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury
doi 10.3389/fphar.2020.592238
- 4,940 views
- 53 citations
MINI REVIEW
Published on 30 Sep 2020
Mitochondrial Stress Responses and “Mito-Inflammation” in Cystic Fibrosis
doi 10.3389/fphar.2020.581114
- 5,610 views
- 20 citations
ORIGINAL RESEARCH
Published on 30 Sep 2020
Airway Mucins Inhibit Oxidative and Non-Oxidative Bacterial Killing by Human Neutrophils
doi 10.3389/fphar.2020.554353
- 2,322 views
- 9 citations
REVIEW
Published on 11 Sep 2020
Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
doi 10.3389/fphar.2020.576293
- 3,356 views
- 5 citations
MINI REVIEW
Published on 03 Sep 2020
Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis?
doi 10.3389/fphar.2020.569821
- 3,367 views
- 15 citations
Published in
Frontiers in Pharmacology
- Inflammation Pharmacology
- Respiratory Pharmacology
Participating Journals
Frontiers in Immunology
Inflammation PharmacologyOffline
- 5.7 impact factor
- 9.8 citescore
Impact
- 95kTopic views
- 62kArticle views
- 31kArticle downloads